We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

GRAIL Announces $1B Series B Funding

News   Jan 09, 2017 | Original Story from Illumina

 
GRAIL Announces $1B Series B Funding
 
 
 

RELATED ARTICLES

“Jumping Genes” May Cause Rare Childhood Developmental Disorders

News

Researchers have discovered that so-called “jumping genes” appear to be behind rare developmental disorders in some children.

READ MORE

Study Finds Commercially Available Antibodies Are Not Binding Their Target

News

In a new study, researchers have tested the binding specificity of commercial antibodies to the C9ORF72 protein, and explored a novel validation approach.

READ MORE

Personalized Immunotherapy Refined by Mass Spec-Machine Learning Pairing

News

A combination of mass spectrometry and a novel computational tool is more accurately identifying the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response to tumors and infectious agents.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE